People make a lot of wishes, hoping for a “magic pill” when it comes to weight loss. Many women have even started taking ...

Many people who struggle with weight management may experience an uncontrollable, near-obsessive preoccupation with food. | ...

Sept. 19, 2024 – Older and middle-aged people who followed the MIND diet for at least 1 year had less and slower cognitive decline, compared to people with significantly different diets. The benefits ...

A new weight loss pill developed by the maker of Ozempic and Wegovy helped overweight and obese people lose up to 13% of their body weight in three months, an early trial has found. Experts said ...

Kourtney Kardashian is hopping on the weight loss trend with the launch of her ... synthetic GLP-1 hormone and is not a GLP-1 agonist drug,” a press release from the company clarifies.

An experimental weight-loss pill is showing promising results, helping people drop 13% of their body weight in a three-month period. The results from early clinical trials were presented by Novo ...

In terms of efficacy, Roche reiterated its statement in July that the once-daily pill CT-996 resulted in a placebo-adjusted average weight loss of 6.1% within four weeks in obese patients without ...

The U.S. Food and Drug Administration (FDA ... stop the medication and help you choose a different weight loss treatment. Contrave is a twice-daily medication approved only for adults meeting ...

The phase 1 trials also show some mild and moderate side effects, primarily gastrointestinal, similar to those of other weight-loss drugs. The obesity pill could prove stiff competition for Eli ...

The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that delivered weight loss success by taking a daily pill. Novo Nordisk released ...